Barclays reiterated coverage on LHC Group with a new price target
$LHCG
Medical/Nursing Services
Health Care
Barclays reiterated coverage of LHC Group with a rating of Equal-Weight and set a new price target of $171.00 from $207.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/4/2022 | $172.00 → $170.00 | Outperform → Sector Perform | RBC Capital Mkts |
| 3/10/2022 | $175.00 → $185.00 | Buy | Truist Securities |
| 2/28/2022 | $184.00 → $181.00 | Outperform | Credit Suisse |
| 2/24/2022 | $190.00 → $170.00 | Buy | Benchmark |
| 11/10/2021 | $149.00 → $151.00 | Market Perform | SVB Leerink |
| 11/5/2021 | $207.00 → $171.00 | Equal-Weight | Barclays |
| 11/5/2021 | $192.00 → $180.00 | Outperform | RBC Capital |
| 11/5/2021 | $191.00 → $184.00 | Outperform | Credit Suisse |
NEW YORK, Feb. 16, 2023 /PRNewswire/ -- S&P SmallCap 600 constituent UFP Industries Inc. (NASD: UFPI) will replace LHC Group Inc. (NASD: LHCG) in the S&P MidCap 400, and Otter Tail Corp. (NASD: OTTR) will replace UFP Industries in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 23. S&P 500 constituent UnitedHealth Group Inc. (NYSE:UNH) is acquiring LHC Group in a deal expected to be completed soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effectiv
LAFAYETTE, La., Nov. 2, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Financial Results Net service revenue increased 2.0% to $576.9 million.Net income attributable to LHC Group's common stockholders was $17.3 million, or $0.56 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $32.6 million, or $1.06 adjusted earnings per diluted share.Adjusted EBITDA was $60.3 million.A reconciliation of all non-GAAP financial results in this release appea
LAFAYETTE, La., Oct. 19, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the third quarter ended September 30, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, November 2, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the third quarter results. About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around t
LAFAYETTE, La., Nov. 2, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Financial Results Net service revenue increased 2.0% to $576.9 million.Net income attributable to LHC Group's common stockholders was $17.3 million, or $0.56 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $32.6 million, or $1.06 adjusted earnings per diluted share.Adjusted EBITDA was $60.3 million.A reconciliation of all non-GAAP financial results in this release appea
LAFAYETTE, La., Oct. 19, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the third quarter ended September 30, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, November 2, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the third quarter results. About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around t
LAFAYETTE, La., Aug. 3, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended June 30, 2022. Second Quarter 2022 Financial Results Net service revenue increased 5.5% to $576.2 million.Net income attributable to LHC Group's common stockholders was $10.6 million, or $0.35 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $29.8 million, or $0.98 adjusted earnings per diluted share.Adjusted EBITDA was $53.0 million.A reconciliation of all non-GAAP financial results in this release appears o
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
RBC Capital Mkts downgraded LHC Group from Outperform to Sector Perform and set a new price target of $170.00 from $172.00 previously
Truist Securities reiterated coverage of LHC Group with a rating of Buy and set a new price target of $185.00 from $175.00 previously
Credit Suisse reiterated coverage of LHC Group with a rating of Outperform and set a new price target of $181.00 from $184.00 previously
S&P SmallCap 600 constituent UFP Industries Inc. (NASD: UFPI) will replace LHC Group Inc. (NASD: LHCG) in the S&P MidCap 400, and Otter Tail Corp. (NASD: OTTR) will replace UFP Industries in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 23. S&P 500 constituent UnitedHealth Group Inc. (NYSE:UNH) is acquiring LHC Group in a deal expected to be completed soon pending final conditions.
LHC Group (NASDAQ:LHCG) reported quarterly earnings of $1.06 per share which missed the analyst consensus estimate of $1.36 by 22.06 percent. This is a 26.9 percent decrease over earnings of $1.45 per share from the same period last year. The company reported quarterly sales of $576.91 million which missed the analyst consensus estimate of $611.95 million by 5.73 percent. This is a 2.03 percent increase over sales of $565.45 million the same period last year.
S-8 POS - LHC Group, Inc (0001303313) (Filer)
8-K - LHC Group, Inc (0001303313) (Filer)
10-K - LHC Group, Inc (0001303313) (Filer)
SC 13G/A - LHC Group, Inc (0001303313) (Subject)
SC 13G/A - LHC Group, Inc (0001303313) (Subject)
SC 13G/A - LHC Group, Inc (0001303313) (Subject)
Agape Care Group, a leading hospice and palliative care provider, announced today that it is has appointed Carry vandenMaagdenberg as its Chief Technology and Innovation Officer and welcomes Matt Winer to the company as its Chief Operations Officer. Both leaders are health care industry veterans who will lead Agape Care Group forward as it continues to serve a growing number of patients across the Southeast region. Winer joins Agape Care Group from LHC Group (NASDAQ:LHCG) where he led the company's Home Health Division in the Northeast. He has health care experience in South Carolina, having served in operational leadership roles for MUSC Health based in Charleston. He has also led teams i
LAFAYETTE, La., Feb. 17, 2021 /PRNewswire/ -- LHC Group, Inc. (NASDAQ: LHCG) announced a number of corporate governance and board changes that will go into effect with the company's annual shareholder meeting on June 10, 2021. These changes include a mandatory retirement age of 75 for board members as well as the appointment of new chairs of the audit, compensation, corporate development and nominating and corporate governance committees. In addition, LHC Group announced that W.J. "Billy" Tauzin, will retire from the board, effective June 10, 2021. Following a long and distinguished career representing Louisiana's Third Congressional District in the U.S. House of Representatives, Congressm